DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Miller DS. et al.
Phase II trial of topotecan in patients with advanced, persistent, or recurrent uterine leiomyosarcomas: a Gynecologic Oncology Group Study.
Am J Clin Oncol 2000;
23: 355-357
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.